Emergent Biosolutions Inc (NYSE: EBS) kicked off on Tuesday, up 8.53% from the previous trading day, before settling in for the closing price of $9.14. Over the past 52 weeks, EBS has traded in a range of $4.02-$12.73.
While this was happening, its average annual earnings per share was recorded 608.70%. With a float of $51.21 million, this company’s outstanding shares have now reached $53.70 million.
Emergent Biosolutions Inc (EBS) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Emergent Biosolutions Inc is 4.01%, while institutional ownership is 74.48%. The most recent insider transaction that took place on Oct 07 ’25, was worth 306,080. Before that another transaction happened on Aug 15 ’25, when Company’s Director sold 7,086 for $8.87, making the entire transaction worth $62,853. This insider now owns 71,799 shares in total.
Emergent Biosolutions Inc (EBS) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported 1.37 earnings per share (EPS), higher than consensus estimate (set at 0.14) by 1.23. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 608.70% per share during the next fiscal year.
Emergent Biosolutions Inc (NYSE: EBS) Trading Performance Indicators
Take a look at Emergent Biosolutions Inc’s (EBS) current performance indicators. Last quarter, stock had a quick ratio of 3.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.62. Likewise, its price to free cash flow for the trailing twelve months is 3.41.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.45, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 1.02 in one year’s time.
Technical Analysis of Emergent Biosolutions Inc (EBS)
Looking closely at Emergent Biosolutions Inc (NYSE: EBS), its last 5-days average volume was 0.91 million, which is a drop from its year-to-date volume of 1.21 million. As of the previous 9 days, the stock’s Stochastic %D was 85.72%.
During the past 100 days, Emergent Biosolutions Inc’s (EBS) raw stochastic average was set at 97.25%, which indicates a significant increase from 94.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.44 in the past 14 days, which was higher than the 0.42 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.19, while its 200-day Moving Average is $7.36. However, in the short run, Emergent Biosolutions Inc’s stock first resistance to watch stands at $10.24. Second resistance stands at $10.57. The third major resistance level sits at $11.09. If the price goes on to break the first support level at $9.40, it is likely to go to the next support level at $8.88. Now, if the price goes above the second support level, the third support stands at $8.56.
Emergent Biosolutions Inc (NYSE: EBS) Key Stats
The company with the Market Capitalisation of 529.24 million has total of 53,351K Shares Outstanding. Its annual sales at the moment are 1,044 M in contrast with the sum of -190,600 K annual income. Company’s last quarter sales were recorded 140,900 K and last quarter income was -12,000 K.
